goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Group B Streptococcal Disease in the Perinatal Period

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Group B Streptococcal Disease in the Perinatal Period

Sponsored by The Indian Health Service Clinical Support Center

1. How to participate

For more details about how to participate in this C.E.U./C.M.E. program, see the Perinatologist Corner page. Also see specifics there on Goals, Sponsorship and Credit, and Disclosure.

Goal and objectives

Goals

The student will understand the maternal and fetal consequences, methods and limitations of screening, and understand the management of Group B Streptococcal disease in the perinatal period.

Objectives

The objectives for this module are:

  • The student will understand the maternal and fetal consequences of Group B Streptococcal disease in the perinatal period.
  • The student will understand the methods and limitations of Group B Streptococcal disease in the perinatal period.
  • The student will understand the management of Group B Streptococcal disease in the perinatal period

Case scenarios

Case 1

Belinda Quapaw is a 21 y/o G1P0 at 35 weeks gestation who is admitted with a temperature of 101.2 degrees F and strong, painful uterine contractions occurring every 1-2 minutes. Her uterus is tender to palpation and her cervix is 7 cm dilated, 90% effaced, with a vertex presentation at +1 station. The fetal heart rate is 180 bpm with reduced variability. Membranes spontaneously rupture producing turbid but nonmalodorous fluid. She has not yet been screened for GBS. She has no allergies. Is antibiotic therapy appropriate for her at this time? If so, which drug(s) would you use?

Next › 2. Background and bacteriology

up arrow Return to top of page

This file last modified: Friday July 6, 2007  2:05 PM